Keynote Presentation: Clinical & Mechanistic Perspective on Bringing Cell Therapies to Autoimmune Disease
- Introducing RNA engineering for cell therapy
- Demonstrating deep and durable responses in patients receiving Descartes-08 without lymphodepletion or inpatient administration
- Insight into mechanisms behind Cartesian Therapeutics’ lead asset, Descartes-08